ImmunityBio (IBRX) Research & Development (2014 - 2026)
ImmunityBio's (IBRX) quarterly Research & Development came in at $600000.0 in Q1 2026, little changed year-on-year from $600000.0 in Q1 2025, and up 500.0% on a QoQ basis from $100000.0 in Q3 2025.
ImmunityBio (IBRX) Research & Development (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Research & Development data on file, last reported at $600000.0 in Q1 2026.
- On a quarterly basis, Research & Development changed 0.0% year-over-year to $600000.0 in Q1 2026; TTM through Mar 2026 was $700000.0, a 68.18% decrease from a year earlier, with the FY2024 full-year figure at $2.3 million, up 15.0% from the prior year.
- Research & Development for Q1 2026 stood at $600000.0, up from $100000.0 in the prior quarter.
- Over the last five years, Research & Development for IBRX reached as high as $79.3 million in Q1 2023 and fell as low as -$178.8 million in Q4 2023.
- Historically, Research & Development has averaged $16.9 million across 5 years, with a median of $700000.0 in 2024.
- Across the five-year window, Research & Development tumbled 407.93% in 2023 and soared 100.34% in 2024, its largest moves.
- Year by year, Research & Development stood at $58.1 million in 2022, then tumbled by 407.93% to -$178.8 million in 2023, then soared by 100.34% to $600000.0 in 2024, then plunged by 83.33% to $100000.0 in 2025, then surged by 500.0% to $600000.0 in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $600000.0 in Q1 2026, $100000.0 in Q3 2025, and $600000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | -178.83 Mn |
| Sep 30, 2023 | 48.40 Mn |
| Jun 30, 2023 | 53.17 Mn |
| Mar 31, 2023 | 79.26 Mn |
| Dec 31, 2022 | 58.08 Mn |
| Sep 30, 2022 | 71.61 Mn |
| Jun 30, 2022 | 63.08 Mn |
| Mar 31, 2022 | 55.38 Mn |
| Dec 31, 2021 | 51.75 Mn |
| Sep 30, 2021 | 49.28 Mn |
| Jun 30, 2021 | 53.80 Mn |
| Mar 31, 2021 | 41.13 Mn |
| Dec 31, 2020 | 43.36 Mn |